Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Inventory: 2016-2024

Historic Inventory for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $35.6 million.

  • Collegium Pharmaceutical's Inventory rose 0.05% to $38.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year increase of 0.05%. This contributed to the annual value of $35.6 million for FY2024, which is 9.98% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Inventory is $35.6 million, which was up 9.98% from $32.3 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Inventory ranged from a high of $46.5 million in FY2022 and a low of $15.6 million during FY2020.
  • For the 3-year period, Collegium Pharmaceutical's Inventory averaged around $38.1 million, with its median value being $35.6 million (2024).
  • In the last 5 years, Collegium Pharmaceutical's Inventory surged by 167.34% in 2022 and then crashed by 30.47% in 2023.
  • Yearly analysis of 5 years shows Collegium Pharmaceutical's Inventory stood at $15.6 million in 2020, then grew by 11.40% to $17.4 million in 2021, then spiked by 167.34% to $46.5 million in 2022, then tumbled by 30.47% to $32.3 million in 2023, then increased by 9.98% to $35.6 million in 2024.